Trazimera
NDC 0069-0308, trastuzumab-qyyp, injection, powder, lyophilized, for solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-0308
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761081
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRASTUZUMAB150 mg/7.15mL
Pharmacologic classes
HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-0308-01 | 00069030801 | 1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b9c5e894-27d2-4245-a653-df986fed3c56Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0069-0308
Use it
Look up 0069-0308 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-0308. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.